Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2020

01-12-2020 | Osteoarthrosis | Research

Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis

Authors: Jesús Martín-Fernández, Mariel Morey-Montalvo, Nuria Tomás-García, Elena Martín-Ramos, Juan Carlos Muñoz-García, Elena Polentinos-Castro, Gemma Rodríguez-Martínez, Juan Carlos Arenaza, Lidia García-Pérez, Laura Magdalena-Armas, Amaia Bilbao

Published in: Health and Quality of Life Outcomes | Issue 1/2020

Login to get access

Abstract

Background

The EQ-5D-5 L is a quality-of-life questionnaire based on individuals’ preferences that is widely employed for cost-effectiveness analysis. Given the current demand for mapping algorithms to directly assign “utilities”, this study aimed to generate different mapping models for predicting EQ-5D-5 L utility values based on scores of the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires provided by patients suffering from hip and knee osteoarthritis (OA), respectively, and to assess the predictive capability of these functions.

Methods

This was a prospective, observational study. Following the criteria of the American Rheumatism Association, 361 patients with hip OA and 397 with knee OA from three regions in Spain were included. Health-related quality of life (HRQoL) was assessed through the EQ-5D-5 L general questionnaire and the OHS and OKS specifically for lower limb OA.
Based on the scores on the OHS and OKS questionnaires, EQ-5D-5 L utilities were estimated using 4 models: ordinary least squares (OLS), Tobit, generalized linear model (GLM), and beta regression (Breg).
The models were validated on the same patients after 6 months: the mean absolute error (MAE) and mean squared error (MSE) with their 95% confidence intervals (CI), mean values of standard errors (SE), intraclass correlation coefficients (ICC), and Bland-Altman plots were obtained.

Results

The lowest MAEs were obtained using GLM and Breg models, with values of 0.1103 (0.0993–0.1214) and 0.1229 (0.1102–0.1335) for hip OA, and values of 0.1127 (0.1014–0.1239) and 0.1141 (0.1031–0.1251) for knee OA. MSE values were also lower using GLM and Breg. ICCs between predicted and observed values were around or over the 0.8 cut-off point. Bland-Altman plots showed an acceptable correlation, but precision was lower for subjects with worse HRQoL, which was also evident when comparing MAEs of the bottom and top halves of the utilities scale. Predictive equations for utilities based on OHS/OKS scores were proposed.

Conclusions

The OHS and OKS scores allow for estimating EQ-5D-5 L utility indexes for patients with hip and knee OA, respectively, with adequate validity and precision. GLM and Breg produce the best predictions. The predictive power of proposed equations is more consistent for subjects in better health condition.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wailoo AJ, Hernandez-Alava M, Manca A, Mejia A, Ray J, Crawford B, et al. Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report. Value Heal. Elsevier Inc. 2017;20:18–27.CrossRef Wailoo AJ, Hernandez-Alava M, Manca A, Mejia A, Ray J, Crawford B, et al. Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report. Value Heal. Elsevier Inc. 2017;20:18–27.CrossRef
2.
go back to reference Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, et al. Cost-effectiveness analysis alongside clinical trials II - an ISPOR good research practices task force report. Value Heal Elsevier. 2015;18:161–72.CrossRef Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, et al. Cost-effectiveness analysis alongside clinical trials II - an ISPOR good research practices task force report. Value Heal Elsevier. 2015;18:161–72.CrossRef
3.
go back to reference Bleichrodt H, Johannesson M. Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs. J Health Econ. 1997;16:155–75.PubMedCrossRef Bleichrodt H, Johannesson M. Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs. J Health Econ. 1997;16:155–75.PubMedCrossRef
5.
6.
go back to reference Dakin H, Abel L, Burns R, Yang Y. Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement. Health Qual Life Outcomes. 2018;16:1–9.CrossRef Dakin H, Abel L, Burns R, Yang Y. Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement. Health Qual Life Outcomes. 2018;16:1–9.CrossRef
7.
go back to reference Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, et al. Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement. Qual Life Res. 2016;25:275–81.PubMedCrossRef Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, et al. Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement. Qual Life Res. 2016;25:275–81.PubMedCrossRef
8.
go back to reference Ramos-Goñi JM, Pinto-Prades JL, Oppe M, Cabasés JM, Serrano-Aguilar P, Rivero-Arias O. Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med Care. 2017;55:e51–8.PubMedCrossRef Ramos-Goñi JM, Pinto-Prades JL, Oppe M, Cabasés JM, Serrano-Aguilar P, Rivero-Arias O. Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med Care. 2017;55:e51–8.PubMedCrossRef
9.
go back to reference National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. London: National Institute for Health and Care Excellence (NICE); 2013. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. London: National Institute for Health and Care Excellence (NICE); 2013.
10.
go back to reference Ramos-Goñi JM, Craig BM, Oppe M, Ramallo-Fariña Y, Pinto-Prades JL, Luo N, et al. Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach. Value Health. Elsevier Inc. 2018;21:596–604.PubMedCrossRef Ramos-Goñi JM, Craig BM, Oppe M, Ramallo-Fariña Y, Pinto-Prades JL, Luo N, et al. Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach. Value Health. Elsevier Inc. 2018;21:596–604.PubMedCrossRef
11.
go back to reference Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1323–30.PubMedCrossRef Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1323–30.PubMedCrossRef
12.
go back to reference Martín-Fernández J, García-Maroto R, Bilbao A, García-Pérez L, Gutiérrez-Teira B, Molina-Siguero A, et al. Impact of lower limb osteoarthritis on health-related quality of life: A cross-sectional study to estimate the expressed loss of utility in the Spanish population. PLoS One. 2020;15:e0228398.PubMedPubMedCentralCrossRef Martín-Fernández J, García-Maroto R, Bilbao A, García-Pérez L, Gutiérrez-Teira B, Molina-Siguero A, et al. Impact of lower limb osteoarthritis on health-related quality of life: A cross-sectional study to estimate the expressed loss of utility in the Spanish population. PLoS One. 2020;15:e0228398.PubMedPubMedCentralCrossRef
13.
go back to reference Loza E, Lopez-Gomez JM, Abasolo L, Maese JJ, Carmona L, Batlle-Gualda E. Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum. 2009;61:158–65.PubMedCrossRef Loza E, Lopez-Gomez JM, Abasolo L, Maese JJ, Carmona L, Batlle-Gualda E. Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum. 2009;61:158–65.PubMedCrossRef
14.
go back to reference Puig-Junoy J, Ruiz ZA. Socio-economic costs of osteoarthritis: a systematic review of cost-of-illness studies. Semin Arthritis Rheum. 2015;44:531–41.PubMedCrossRef Puig-Junoy J, Ruiz ZA. Socio-economic costs of osteoarthritis: a systematic review of cost-of-illness studies. Semin Arthritis Rheum. 2015;44:531–41.PubMedCrossRef
15.
go back to reference Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–40.PubMed Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–40.PubMed
16.
go back to reference Escobar A, Quintana JM, Bilbao A, Azkárate J, Güenaga JI. Validation of the Spanish version of the WOMAC questionnaire for patients with hip or knee osteoarthritis. Western Ontario and McMaster universities osteoarthritis index. Clin Rheumatol. 2002;21:466–71.PubMedCrossRef Escobar A, Quintana JM, Bilbao A, Azkárate J, Güenaga JI. Validation of the Spanish version of the WOMAC questionnaire for patients with hip or knee osteoarthritis. Western Ontario and McMaster universities osteoarthritis index. Clin Rheumatol. 2002;21:466–71.PubMedCrossRef
17.
go back to reference Martin RL, Kelly BT, Philippon MJ. Evidence of validity for the hip outcome score. Arthroscopy. 2006;22:1304–11.PubMedCrossRef Martin RL, Kelly BT, Philippon MJ. Evidence of validity for the hip outcome score. Arthroscopy. 2006;22:1304–11.PubMedCrossRef
18.
go back to reference Seijas R, Sallent A, Ruiz-Ibán MA, Ares O, Marín-Peña O, Cuéllar R, et al. Validation of the Spanish version of the hip outcome score: a multicenter study. Health Qual Life Outcomes. 2014;12:70.PubMedPubMedCentralCrossRef Seijas R, Sallent A, Ruiz-Ibán MA, Ares O, Marín-Peña O, Cuéllar R, et al. Validation of the Spanish version of the hip outcome score: a multicenter study. Health Qual Life Outcomes. 2014;12:70.PubMedPubMedCentralCrossRef
19.
go back to reference Irrgang JJ, Anderson AF, Boland AL, Harner CD, Kurosaka M, Neyret P, et al. Development and validation of the international knee documentation committee subjective knee form. Am J Sports Med. American Orthopaedic Society for Sports Medicine. 2001;29:600–13.PubMedCrossRef Irrgang JJ, Anderson AF, Boland AL, Harner CD, Kurosaka M, Neyret P, et al. Development and validation of the international knee documentation committee subjective knee form. Am J Sports Med. American Orthopaedic Society for Sports Medicine. 2001;29:600–13.PubMedCrossRef
20.
go back to reference Ares O, Castellet E, Maculé F, León V, Montañez E, Freire A, et al. Translation and validation of “the knee society clinical rating system” into Spanish. Knee Surg Sport Traumatol Arthrosc. 2013;21:2618–24.CrossRef Ares O, Castellet E, Maculé F, León V, Montañez E, Freire A, et al. Translation and validation of “the knee society clinical rating system” into Spanish. Knee Surg Sport Traumatol Arthrosc. 2013;21:2618–24.CrossRef
21.
go back to reference Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee injury and osteoarthritis outcome score (KOOS)—development of a self-administered outcome measure. J Orthop Sport Phys Ther. 1998;28:88–96.CrossRef Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee injury and osteoarthritis outcome score (KOOS)—development of a self-administered outcome measure. J Orthop Sport Phys Ther. 1998;28:88–96.CrossRef
22.
go back to reference Vaquero J, Longo UG, Forriol F, Martinelli N, Vethencourt R, Denaro V. Reliability, validity and responsiveness of the Spanish version of the knee injury and osteoarthritis outcome score (KOOS) in patients with chondral lesion of the knee. Knee Surg Sport Traumatol Arthrosc. 2014;22:104–8.CrossRef Vaquero J, Longo UG, Forriol F, Martinelli N, Vethencourt R, Denaro V. Reliability, validity and responsiveness of the Spanish version of the knee injury and osteoarthritis outcome score (KOOS) in patients with chondral lesion of the knee. Knee Surg Sport Traumatol Arthrosc. 2014;22:104–8.CrossRef
23.
go back to reference Dawson J, Fitzpatrick R, Carr A, Murray D. Questionnaire on the perceptions of patients about total hip replacement. J Bone Jt Surg. 1996;78-B:185–90.CrossRef Dawson J, Fitzpatrick R, Carr A, Murray D. Questionnaire on the perceptions of patients about total hip replacement. J Bone Jt Surg. 1996;78-B:185–90.CrossRef
24.
go back to reference Dawson J, Fitzpatrick R, Murray D, Carr A. Questionnaire on the perceptions of patients about total knee replacement. J Bone Joint Surg Br. 1998;80:63–9.PubMedCrossRef Dawson J, Fitzpatrick R, Murray D, Carr A. Questionnaire on the perceptions of patients about total knee replacement. J Bone Joint Surg Br. 1998;80:63–9.PubMedCrossRef
25.
go back to reference Martín-Fernández J, Gray-Laymón P, Molina-Siguero A, Martínez-Martín J, García-Maroto R, García-Sánchez I, et al. Cross-cultural adaptation and validation of the Spanish version of the Oxford Hip Score in patients with hip osteoarthritis. BMC Musculoskelet Disord. 2017;18:205.PubMedPubMedCentralCrossRef Martín-Fernández J, Gray-Laymón P, Molina-Siguero A, Martínez-Martín J, García-Maroto R, García-Sánchez I, et al. Cross-cultural adaptation and validation of the Spanish version of the Oxford Hip Score in patients with hip osteoarthritis. BMC Musculoskelet Disord. 2017;18:205.PubMedPubMedCentralCrossRef
26.
go back to reference Martín-Fernández J, García-Maroto R, Sánchez-Jiménez FJ, Bau-González A, Valencia-García H, Gutiérrez-Teira B, et al. Validation of the Spanish version of the Oxford knee score and assessment of its utility to characterize quality of life of patients suffering from knee osteoarthritis: a multicentric study. Health Qual Life Outcomes. 2017;15:186.PubMedPubMedCentralCrossRef Martín-Fernández J, García-Maroto R, Sánchez-Jiménez FJ, Bau-González A, Valencia-García H, Gutiérrez-Teira B, et al. Validation of the Spanish version of the Oxford knee score and assessment of its utility to characterize quality of life of patients suffering from knee osteoarthritis: a multicentric study. Health Qual Life Outcomes. 2017;15:186.PubMedPubMedCentralCrossRef
27.
go back to reference Dakin H, Gray A, Murray D. Mapping analyses to estimate EQ-5D utilities and responses based on Oxford knee score. Qual Life Res. 2013;22:683–94.PubMedCrossRef Dakin H, Gray A, Murray D. Mapping analyses to estimate EQ-5D utilities and responses based on Oxford knee score. Qual Life Res. 2013;22:683–94.PubMedCrossRef
28.
go back to reference Pinedo-Villanueva RA, Turner D, Judge A, Raftery JP, Arden NK. Mapping the Oxford hip score onto the EQ-5D utility index. Qual Life Res. 2013;22:665–75.PubMedCrossRef Pinedo-Villanueva RA, Turner D, Judge A, Raftery JP, Arden NK. Mapping the Oxford hip score onto the EQ-5D utility index. Qual Life Res. 2013;22:665–75.PubMedCrossRef
29.
go back to reference Altman RD. Criteria for classification of clinical osteoarthritis. J Rheumatol Suppl. 1991;27:10–2.PubMed Altman RD. Criteria for classification of clinical osteoarthritis. J Rheumatol Suppl. 1991;27:10–2.PubMed
30.
go back to reference Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039–49.PubMedCrossRef Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039–49.PubMedCrossRef
31.
go back to reference Knofczynski GT, Mundfrom D. Sample sizes when using multiple linear regression for prediction. Educ Psychol Meas. 2008;68:431–42.CrossRef Knofczynski GT, Mundfrom D. Sample sizes when using multiple linear regression for prediction. Educ Psychol Meas. 2008;68:431–42.CrossRef
32.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.PubMedCrossRef
33.
go back to reference Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.PubMedPubMedCentralCrossRef Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.PubMedPubMedCentralCrossRef
34.
go back to reference Murray DW. Fitzpatrick R, Rogers K, Pandit H, Beard DJ, Carr a J, et al. the use of the Oxford hip and knee scores. J Bone Jt Surg. 2007;89:1010–4.CrossRef Murray DW. Fitzpatrick R, Rogers K, Pandit H, Beard DJ, Carr a J, et al. the use of the Oxford hip and knee scores. J Bone Jt Surg. 2007;89:1010–4.CrossRef
35.
go back to reference Austin PC, Escobar M, Kopec JA. The use of the Tobit model for analyzing measures of health status. Qual Life Res. 2000;9:901–10.PubMedCrossRef Austin PC, Escobar M, Kopec JA. The use of the Tobit model for analyzing measures of health status. Qual Life Res. 2000;9:901–10.PubMedCrossRef
36.
go back to reference Sullivan PW. Are utilities bounded at 1.0? Implications for statistical analysis and scale development. Med Decis Mak. 2011;31:787–9.CrossRef Sullivan PW. Are utilities bounded at 1.0? Implications for statistical analysis and scale development. Med Decis Mak. 2011;31:787–9.CrossRef
37.
go back to reference Basu A, Manca A. Regression estimators for generic health-related quality of life and quality-adjusted life years. Med Decis Mak. 2012;32:56–69.CrossRef Basu A, Manca A. Regression estimators for generic health-related quality of life and quality-adjusted life years. Med Decis Mak. 2012;32:56–69.CrossRef
38.
go back to reference Long JS, Ervin LH. Using heteroscedasticity consistent standard errors in the linear regression model. Am Stat Taylor Francis. 2000;54:217–24. Long JS, Ervin LH. Using heteroscedasticity consistent standard errors in the linear regression model. Am Stat Taylor Francis. 2000;54:217–24.
39.
go back to reference Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327:307–10.CrossRef Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327:307–10.CrossRef
40.
go back to reference Oppe M, Devlin N, Black N. Comparison of the underlying constructs of the EQ-5D and oxford hip score: Implications for mapping. Value Heal. Elsevier Inc. 2011;14:884–91.CrossRef Oppe M, Devlin N, Black N. Comparison of the underlying constructs of the EQ-5D and oxford hip score: Implications for mapping. Value Heal. Elsevier Inc. 2011;14:884–91.CrossRef
41.
go back to reference Conaghan PG, Emerton M, Tennant A. Internal construct validity of the Oxford knee scale: evidence from Rasch measurement. Arthritis Rheum. 2007;57:1363–7.PubMedCrossRef Conaghan PG, Emerton M, Tennant A. Internal construct validity of the Oxford knee scale: evidence from Rasch measurement. Arthritis Rheum. 2007;57:1363–7.PubMedCrossRef
42.
go back to reference Harris KK, Price AJ, Beard DJ, Fitzpatrick R, Jenkinson C, Dawson J. Can pain and function be distinguished in the Oxford hip score in a meaningful way? : an exploratory and confirmatory factor analysis. Bone Joint Res. 2014;3:305–9.PubMedPubMedCentralCrossRef Harris KK, Price AJ, Beard DJ, Fitzpatrick R, Jenkinson C, Dawson J. Can pain and function be distinguished in the Oxford hip score in a meaningful way? : an exploratory and confirmatory factor analysis. Bone Joint Res. 2014;3:305–9.PubMedPubMedCentralCrossRef
43.
go back to reference Harris K, Dawson J, Doll H, Field RE, Murray DW, Fitzpatrick R, et al. Can pain and function be distinguished in the Oxford knee score in a meaningful way? An exploratory and confirmatory factor analysis. Qual Life Res Springer. 2013;22:2561–8.CrossRef Harris K, Dawson J, Doll H, Field RE, Murray DW, Fitzpatrick R, et al. Can pain and function be distinguished in the Oxford knee score in a meaningful way? An exploratory and confirmatory factor analysis. Qual Life Res Springer. 2013;22:2561–8.CrossRef
44.
go back to reference Gray AM, Rivero-Arias O, Clarke PM. Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Mak. 2006;26:18–29.CrossRef Gray AM, Rivero-Arias O, Clarke PM. Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Mak. 2006;26:18–29.CrossRef
45.
go back to reference Reito A, Järvistö A, Jämsen E, Skyttä E, Remes V, Huhtala H, et al. Translation and validation of the 12-item Oxford knee score for use in Finland. BMC Musculoskelet Disord. 2017;18:74.PubMedPubMedCentralCrossRef Reito A, Järvistö A, Jämsen E, Skyttä E, Remes V, Huhtala H, et al. Translation and validation of the 12-item Oxford knee score for use in Finland. BMC Musculoskelet Disord. 2017;18:74.PubMedPubMedCentralCrossRef
46.
go back to reference Paulsen A, Odgaard A, Overgaard S. Translation, cross-cultural adaptationand validation of the Danish version of the Oxford hip score: assessed against generic and disease-specific questionnaires. Bone Jt Res. 2012;1:225–33.CrossRef Paulsen A, Odgaard A, Overgaard S. Translation, cross-cultural adaptationand validation of the Danish version of the Oxford hip score: assessed against generic and disease-specific questionnaires. Bone Jt Res. 2012;1:225–33.CrossRef
47.
go back to reference Norman G. Likert scales, levels of measurement and the “laws” of statistics. Adv Heal Sci Educ. 2010;15:625–32.CrossRef Norman G. Likert scales, levels of measurement and the “laws” of statistics. Adv Heal Sci Educ. 2010;15:625–32.CrossRef
48.
go back to reference Sungher DK, Diamantopoulos A. Mapping the Oxford hip score (OHS) to EQ-5D: a test of model performance. Value Heal. 2013;16:A606.CrossRef Sungher DK, Diamantopoulos A. Mapping the Oxford hip score (OHS) to EQ-5D: a test of model performance. Value Heal. 2013;16:A606.CrossRef
49.
go back to reference Hernaez R. Reliability and agreement studies: a guide for clinical investigators. Gut. 2015;64:1018–27.PubMedCrossRef Hernaez R. Reliability and agreement studies: a guide for clinical investigators. Gut. 2015;64:1018–27.PubMedCrossRef
50.
go back to reference Bilbao A, Martín-Fernández J, García-Pérez L, Arenaza JC, Ariza-Cardiel G, Ramallo-Fariña Y, et al. Mapping WOMAC onto the EQ-5D-5L utility index in patients with hip or knee osteoarthritis. Value Heal. 2020;23(3):379–87. Bilbao A, Martín-Fernández J, García-Pérez L, Arenaza JC, Ariza-Cardiel G, Ramallo-Fariña Y, et al. Mapping WOMAC onto the EQ-5D-5L utility index in patients with hip or knee osteoarthritis. Value Heal. 2020;23(3):379–87.
51.
go back to reference Marriott E, van Hazel G, Gibbs P, Hatswell AJ. Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer. J Med Econ. 2017;20:193–9.PubMedCrossRef Marriott E, van Hazel G, Gibbs P, Hatswell AJ. Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer. J Med Econ. 2017;20:193–9.PubMedCrossRef
52.
go back to reference Luo N, Cheung YB, Ng R, Lee CF. Mapping and direct valuation : do they give equivalent EQ-5D-5L index scores ? Health Qual Life Outcomes. 2015:1–9. Luo N, Cheung YB, Ng R, Lee CF. Mapping and direct valuation : do they give equivalent EQ-5D-5L index scores ? Health Qual Life Outcomes. 2015:1–9.
Metadata
Title
Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis
Authors
Jesús Martín-Fernández
Mariel Morey-Montalvo
Nuria Tomás-García
Elena Martín-Ramos
Juan Carlos Muñoz-García
Elena Polentinos-Castro
Gemma Rodríguez-Martínez
Juan Carlos Arenaza
Lidia García-Pérez
Laura Magdalena-Armas
Amaia Bilbao
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2020
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-020-01435-8

Other articles of this Issue 1/2020

Health and Quality of Life Outcomes 1/2020 Go to the issue